| Bibliography
-
Behan WM, More 1A, Behan PO. Mitochondrial
abnormalities in the postviral fatigue syndrome. Acta Neuropathol
(Berl). 1991;83(l):61-5.
-
Behan P, Behan W and Horrobin D. Effect of
high doses of essential fatty acids on the postviral fatigue
syndrome Acta Neural Scand 1990;82:209-216.
-
Sennett RM, Adult growth hormone deficiency
in patients with fibromyalgia, Curr Rheumat,~il Rep. 2002
Aug;4(4):30612. Review.
-
Berwaerts J, Moorkens G, Abs A. Secretion
of growth hormone in patients with chronic fatigue syndrome.
Growth Horm 1GF Res, 1998 Apr;8 Suppi B127-9.
-
Suchwald D, Herrell K Ashton S, Belcourt
M. Schnnaling K Sullivan P, Neale M, Goldberg J. A lwin study
of chronic fatigue, Psychosom Mod, 2001 NovDec:63(6): 936-43.
-
Caplan At, The mesengenic process. Chn Plast
Surg. 1994 Jul;21(3):429-36.
-
Craveri F, De Pascale V. Activity of orally
administered adrenocortical extract. 1. Effect on the survival
test, Boll Chim Farm 1971;110:457-6Z.
-
Craveri F, De Pascale V, Activity of orally
administered adrenocortical extract. 11. Effect on liver glycogenesis
and sodium retention, "Chim Farm 1971;110:457-62.
-
Craved F. De Pascale V, Activity of orally
administered adrenocortical extract, ill. Effect in tests
based on muscular work. Soft Chim Farm 1971;110:457-62.
-
DeMeirleir K, Bisbal C, Campine 1, De Becker,
P, Salehzada, T, Demettre, E and Lebleu, BA. A 37 kDa 25A
binding protein as a potential biochemical marker for chronic
fatigue syndrome. Am J Mod, 2000~ (108);99-106.
-
Demitrack MA Crofford U. Evidence for and
pathophysiologic implications of hypothalamic-pituitary -adrenal
axis dysregulation in fibromyalgia and chronic fatigue syndrome,
Ann N YAW Sci. 1998 May 1:840:684-97. Review.
-
Dowsett EG, Ramsay
AM, McCartney RA, Bell EJ. Myalgic encephalomyelifis-a persistent
enteroviral infection? PostgradMed./, l9go Jul;66(777):526-30.
-
Farrar DJ, Locke SE, Kantrowitz FG Chronic Fatigue Syndrome,l:
Etiology and Pathogenesis Behavioral
Medicine. 1995; 21 (1)~ 5-16.
-
Fulle S, Mecocci P, Fano G, Vecchiet 1, Vecchini A, Racciotti
D, Cherubini A, Pizzigallo E, Vecchiet L. Senin U, Beal MF.
Specific oxidative alterations in vastus lateralis muscle
of patients with the diagnosis of chronic fatigue syndrome.
Free Radic Biol Med. 2000 Dec
15:29(12):1252-9.
-
Gaab J, Huster 0, Peisen R, Engert V, Schad T, Schurmeyer
TH, Ehlert U, Low-dose dexamethasone suppression lest in chronic
fatigue syndrome and health. Psychosom Mad. 2002 Mar-Apr;&4(2):31l8.
-
Ho-Yen Do. McNamara 1. General practitioners' experience of
the chronic fatigue syndrome.
Br J Gen Pract. 199 1: Aug; 41(349):324-6.
-
Katon W, Walker E. The relationship of chronic fatigue to
psychiatric illness in community, primary care and tertiary
care samples, Chronic fatigue
syndrome New York: Wiley, John & Sons Inc, 1993 Ciba Foundation
Symposia Series: no 173:193-211.
-
Keller RH, Lane JL, Klimas N, Reiter WM, Fletcher MA, van
Riel F, Morgan R, Association of HLA class 11 antigens arid
chronic fatigue immune dysfunction syndrome. Clin Infect Dis,
1994; (18): S154-6.
-
Klein R, Berg PA, High incidence of antibodies to 5-hydroxy-tryptamine,
gangliosides and phospholipids in patients with chronic fatigue
and fibromyalgia syndrome and their relatives: evidence for
a clinical entity of both disorders, Eur
J Mad Res, 1995; (1):21-6.
-
Landay AL, Jessop C, Lennette ET, Levyk JA Chronic Fatigue
Syndrome: clinical condition associated with immune activation.
Lancet, 1991; (338) no 8769: 707-12.
-
Lane RJ, Barrett MC,
Woodrow D, Moss J, Fletcher R, Archard LC. Muscle fibre characteristics
and lactate responses to exercise in chronic fatigue syndrome,
J Neurof Neurosurg Psychiatry,
1998 Mar;64(3):362-7.
-
Levine PH, Whiteside TL, Friberg D, Bryant J, Colclough G.
Herberman RB. Dysfunction of natural killer activity in a
family with chronic fatigue syndrome, Clin immunol Immunopathol,
1998: (88):96-104.
-
Leal-Cerro A, Povedano J. Astorga R. Gonzalez M. Silva H.
Garcia-Pesquera F, Casanueva FF, Dieguez C. The growth hormone
(GH) - releasing hormone-GHinsulin-like growth factor-1 axis
in patients with fibromyalgia syndrome. J Clin
Endocrinol Metab, 1999 Sep;84(9):3378-81.
-
Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress
and dietary modifications. Altern
Mad Rev, 2001 Oct:6(5):450-9 Review.
-
MacHale SM, Cavanagh JT, Bennie J, Carroll S, Goodwin GM,
Lawrie SM. Diurnal variation of adrenocortical activity in
chronic fatigue syndrome. Neuropsychobiology,
1998 Nov;38(4):2137.
-
Manian FA Simultaneous measurement of antibodies to Epstein-Barr
virus, human herpesvirus 6, herpes simplex virus types I and
2, and 14 enteroviruses in chronic fatigue syndrome: is there
evidence of activation of a nonspecific polyclonal immune
response? Clin Infect Dis. 1994 Sep;19(3):448-53.
-
McCully KK, Natelson
BH, lotti S, Sisto S, Leigh JS Jr, Reduced oxidative muscle
metabolism in chronic fatigue syndrome, Muscle Nerve, 1996
May; 19(5):621-5.
-
Niehans P, Introduction to
cellular therapy. New York, NY. Pageant books, 1960.
-
OttenwellerJE, Sistc, SA, McCarty RC, Natelson BH. Hormonal
responses to exercise in chronic fatigue syndrome. Neuropsychobiology.
2001 Jan;43(1):3441.
-
Redman DA, Ruscus aculeatus
(butcher's broom) as a potential treatment for orthostatic
hypotension, with a case report, J Altern Complement Med.
2000 Dec;6(6)539-49.
-
Richards RS Roberts TK, McGregor NR, Dunstan RH. Butt HL.
Stood parameters indicative of oxidative stress are associated
with symptom expression in chronic fatigue syndrome.
Redox Rep, 2000;5(1):35-41.
-
Shepherd C. Hydrocortisone and chronic fatigue syndrome,
Lancet. 1999 May 8;353(9164). 1619-20.
-
Scott LV, Teh J, Reznek
R, Martin A, Sohaib A, Dinan TG, Small adrenal glands in chronic
fatigue syndrome: a preliminary computer tomography study
Psychoneuro endocrinology,
1999; (24): 759-68.
-
Scott LV, Medbak S, Dinan TG. Blunted adrenocorticotropin
and cortisol responses to cortocotropic -releasing hormone
stimulation in chronic fatigue syndrome. Acta Psychiatr Scand
1998:97:450-457.
-
US Department of Health
and Human Services, National Center for Infectuous diseases,
Centers for Disease Control and Prevention. The facts about
chronic fatigue syndrome, Atlanta, GA, 1995.
-
Walsh CM. Zainal NZ,
Middleton SJ, Paykel ES
A family history study of chronic fatigue
syndrome, Psychiatr Genat, 2001; Sep;11(3):123-8.
-
Wolfe F. Russell IJ,
Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold,
and fibromyalgia symptoms in the general population. J
Rheumatol, 1997
(24):555-9.
<:::Back
| Table
of Contents |
2003
Alternative Medicine Solutions, Inc. All Rights Reserved 3/19
©CF Support Scientific Review |
